Free Trial

Corteva (CTVA) Financials

Corteva logo
$60.28 +1.00 (+1.69%)
As of 04/14/2025 03:58 PM Eastern
Annual Income Statements for Corteva

Annual Income Statements for Corteva

This table shows Corteva's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
-5,065 -959 681 1,759 1,147 735 907
Consolidated Net Income / (Loss)
-5,027 -941 701 1,769 1,158 747 919
Net Income / (Loss) Continuing Operations
-6,775 -270 756 1,822 1,216 941 863
Total Pre-Tax Income
-6,806 -316 675 2,346 1,426 1,093 1,275
Total Operating Income
-6,637 -382 508 1,028 1,565 1,774 1,808
Total Gross Profit
4,339 5,271 5,710 6,435 7,019 7,306 7,379
Total Revenue
14,287 13,846 14,217 15,655 17,455 17,226 16,908
Operating Revenue
14,287 13,846 14,217 15,655 17,455 17,226 16,908
Total Cost of Revenue
9,948 8,575 8,507 9,220 10,436 9,920 9,529
Operating Cost of Revenue
9,948 8,575 8,507 9,220 10,436 9,920 9,529
Total Operating Expenses
10,976 5,653 5,202 5,407 5,454 5,532 5,571
Selling, General & Admin Expense
3,041 3,065 3,043 3,209 3,173 3,176 3,196
Research & Development Expense
1,355 1,147 1,142 1,187 1,216 1,337 1,402
Amortization Expense
391 475 682 722 702 683 685
Restructuring Charge
694 222 335 289 363 336 288
Total Other Income / (Expense), net
-169 66 167 1,318 -139 -681 -533
Interest Expense
418 149 45 30 79 233 233
Other Income / (Expense), net
249 215 212 1,348 -60 -448 -300
Income Tax Expense
-31 -46 -81 524 210 152 412
Net Income / (Loss) Discontinued Operations
1,748 -671 -55 -53 -58 -194 56
Net Income / (Loss) Attributable to Noncontrolling Interest
38 18 20 10 11 12 12
Basic Earnings per Share
($6.76) ($1.28) $0.91 $2.39 $1.59 $1.04 $1.31
Weighted Average Basic Shares Outstanding
- 749.40M 744.06M 727.02M 712.82M 701.78M 685.56M
Diluted Earnings per Share
($6.76) ($1.28) $0.91 $2.37 $1.58 $1.03 $1.30
Weighted Average Diluted Shares Outstanding
- 749.40M 744.06M 727.02M 712.82M 701.78M 685.56M
Weighted Average Basic & Diluted Shares Outstanding
- 749.40M 744.06M 727.02M 712.82M 701.78M 685.56M
Cash Dividends to Common per Share
- $0.26 $0.52 $0.54 - - $0.66

Quarterly Income Statements for Corteva

This table shows Corteva's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
-331 -55 595 714 -321 -253 419 1,053 -524 -41
Consolidated Net Income / (Loss)
-328 -53 599 717 -318 -251 423 1,056 -521 -39
Net Income / (Loss) Continuing Operations
-322 -41 607 880 -315 -231 376 1,056 -519 -50
Total Pre-Tax Income
-396 2,451 776 1,084 -444 -323 482 1,338 -633 88
Total Operating Income
-401 -18 878 1,300 -237 -167 622 1,517 -460 129
Total Gross Profit
898 1,315 2,113 2,908 944 1,341 1,942 3,194 761 1,482
Total Revenue
2,777 3,825 4,884 6,045 2,590 3,707 4,492 6,112 2,326 3,978
Operating Revenue
2,777 3,825 4,884 6,045 2,590 3,707 4,492 6,112 2,326 3,978
Total Cost of Revenue
1,879 2,510 2,771 3,137 1,646 2,366 2,550 2,918 1,565 2,496
Operating Cost of Revenue
1,879 2,510 2,771 3,137 1,646 2,366 2,550 2,918 1,565 2,496
Total Operating Expenses
1,299 1,333 1,235 1,608 1,181 1,508 1,320 1,677 1,221 1,353
Selling, General & Admin Expense
657 764 726 1,045 670 735 736 1,054 671 735
Research & Development Expense
312 340 316 329 335 357 332 357 348 365
Amortization Expense
178 166 160 174 174 175 177 174 170 164
Restructuring Charge
152 63 33 60 2.00 241 75 92 32 89
Total Other Income / (Expense), net
5.00 -185 -102 -216 -207 -156 -140 -179 -173 -41
Interest Expense
18 36 31 82 58 62 41 66 66 60
Other Income / (Expense), net
23 -149 -71 -134 -149 -94 -99 -113 -107 19
Income Tax Expense
-74 -162 169 204 -129 -92 106 282 -114 138
Net Income / (Loss) Discontinued Operations
-6.00 -12 -8.00 -163 -3.00 -20 47 0.00 -2.00 11
Net Income / (Loss) Attributable to Noncontrolling Interest
3.00 2.00 4.00 3.00 3.00 2.00 4.00 3.00 3.00 2.00
Basic Earnings per Share
($0.46) ($0.07) $0.84 $1.00 ($0.45) ($0.35) $0.60 $1.51 ($0.76) ($0.04)
Weighted Average Basic Shares Outstanding
714.49M 712.82M 710.87M 709.76M 704.73M 701.78M 696.98M 692.25M 687.29M 685.56M
Diluted Earnings per Share
($0.46) ($0.07) $0.83 $1.00 ($0.45) ($0.35) $0.60 $1.51 ($0.76) ($0.05)
Weighted Average Diluted Shares Outstanding
714.49M 712.82M 710.87M 709.76M 704.73M 701.78M 696.98M 692.25M 687.29M 685.56M
Weighted Average Basic & Diluted Shares Outstanding
714.49M 712.82M 710.87M 709.76M 704.73M 701.78M 696.98M 692.25M 687.29M 685.56M

Annual Cash Flow Statements for Corteva

This table details how cash moves in and out of Corteva's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
3,613 -2,851 1,700 -198 -2,436 -920 528
Net Cash From Operating Activities
483 1,070 2,064 2,727 1,711 5,225 4,332
Net Cash From Continuing Operating Activities
374 -149 2,064 2,769 1,791 5,345 4,634
Net Income / (Loss) Continuing Operations
-5,027 -941 701 1,822 2,398 1,867 1,756
Consolidated Net Income / (Loss)
5,027 -941 701 1,769 2,282 1,479 1,868
Net Income / (Loss) Discontinued Operations
- - - -53 -116 -388 112
Depreciation Expense
2,790 1,599 1,177 1,243 2,446 2,422 2,454
Non-Cash Adjustments To Reconcile Net Income
5,208 -161 19 -1,117 652 1,762 1,326
Changes in Operating Assets and Liabilities, net
-4,225 -918 167 821 -3,705 -2,474 -902
Net Cash From Discontinued Operating Activities
- - - -42 -80 -80 -302
Net Cash From Investing Activities
-505 -904 -674 -362 -1,264 -6,001 -817
Net Cash From Continuing Investing Activities
-505 -904 -674 -362 -1,264 -3,994 -817
Purchase of Property, Plant & Equipment
-1,501 -1,163 -475 -573 -1,210 -1,190 -1,194
Acquisitions
-8.00 -20 -1.00 -4.00 -96 -2,976 -14
Purchase of Investments
-1,257 -138 -995 -204 -688 -296 -288
Divestitures
78 270 83 75 146 114 10
Sale and/or Maturity of Investments
2,186 160 721 345 590 378 386
Other Investing Activities, net
-3.00 -13 -7.00 -1.00 -6.00 -24 283
Net Cash From Financing Activities
-2,624 -2,929 303 -1,266 -2,327 -175 -2,801
Net Cash From Continuing Financing Activities
3,744 2,357 1,199 -2,563 -2,327 -137 -2,801
Repayment of Debt
-6,422 -6,758 -1,469 -1,800 -3,823 -5,850 -5,825
Repurchase of Common Equity
0.00 -25 -275 -950 -1,000 -756 -1,009
Payment of Dividends
-2,806 511 -448 -397 -418 -439 -2,337
Issuance of Debt
1,156 -867 2,439 484 2,738 6,846 6,250
Other Financing Activities, net
5,448 9,496 56 100 176 62 120
Other Net Changes in Cash
- -88 7.00 - -556 -286 -186
Cash Interest Paid
923 263 36 30 150 468 488
Cash Income Taxes Paid
961 234 229 341 934 1,070 1,414

Quarterly Cash Flow Statements for Corteva

This table details how cash moves in and out of Corteva's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
-4,019 1,998 128 -783 -1,014 749 -2,288 254 1,230 1,332
Net Cash From Operating Activities
-2,677 6,009 -3,311 812 -105 7,829 -5,584 536 -114 9,494
Net Cash From Continuing Operating Activities
-4,326 6,203 -3,302 822 -94 7,919 -5,578 848 -118 9,482
Net Income / (Loss) Continuing Operations
858 1.00 607 880 -315 695 757 2,122 -1,024 -99
Consolidated Net Income / (Loss)
858 -115 599 717 -318 481 851 2,122 -1,028 -77
Net Income / (Loss) Discontinued Operations
- - -8.00 -163 -3.00 -214 94 - -4.00 22
Depreciation Expense
- 608 - - 306 1,523 614 624 612 604
Non-Cash Adjustments To Reconcile Net Income
- 34 68 288 174 1,232 504 450 406 -34
Changes in Operating Assets and Liabilities, net
-7,640 5,560 -5,290 337 -222 2,701 -7,453 -2,348 -112 9,011
Net Cash From Discontinued Operating Activities
- - -9.00 -10 -11 -50 -6.00 -312 4.00 12
Net Cash From Investing Activities
-443 -386 -1,511 -33 -229 -4,228 -540 -70 -322 115
Net Cash From Continuing Investing Activities
-443 -386 1,478 -2,988 -263 -2,221 -540 -70 -322 115
Purchase of Property, Plant & Equipment
-602 -290 -151 -99 -162 -778 -296 -228 -308 -362
Purchase of Investments
-392 -60 0.00 -7.00 -76 -213 -264 -8.00 -2.00 -14
Divestitures
80 54 42 26 -26 72 10 30 -36 6.00
Sale and/or Maturity of Investments
455 42 124 24 21 209 14 146 100 126
Other Investing Activities, net
28 -54 0.00 -2.00 - -22 -4.00 -10 -62 359
Net Cash From Financing Activities
1,226 -3,659 3,274 105 224 -3,778 3,898 -130 1,612 -8,181
Net Cash From Continuing Financing Activities
1,226 -3,659 3,274 105 -671 -2,845 3,898 -130 1,612 -8,181
Repayment of Debt
-1,682 -1,891 -84 -330 -1,869 -3,567 -416 -1,519 -1,172 -2,718
Repurchase of Common Equity
-200 -200 -252 -80 -253 -171 -252 -252 -253 -252
Payment of Dividends
-108 -107 -107 -106 -114 -112 -112 -111 -117 -1,997
Issuance of Debt
3,146 -1,505 3,710 602 1,563 971 4,662 1,712 3,150 -3,274
Other Financing Activities, net
70 44 7.00 19 2.00 34 16 40 4.00 60
Other Net Changes in Cash
- 34 - - - - -62 -82 54 -96

Annual Balance Sheets for Corteva

This table presents Corteva's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024
Total Assets
217,366 42,397 42,649 42,344 42,618 42,996 40,825
Total Current Assets
45,944 13,519 14,768 15,546 16,795 16,260 15,097
Cash & Equivalents
4,540 1,764 3,526 4,459 3,191 2,644 3,106
Short-Term Investments
10 5.00 269 86 124 98 63
Accounts Receivable
10,520 5,528 4,926 4,811 5,701 5,488 5,676
Inventories, net
10,620 5,032 4,882 5,180 6,811 6,899 5,432
Other Current Assets
2,076 1,190 1,165 1,010 968 1,131 820
Plant, Property, & Equipment, net
9,088 4,546 4,396 4,329 4,254 4,287 4,099
Plant, Property & Equipment, gross
14,680 7,872 8,253 8,364 8,551 8,956 9,074
Accumulated Depreciation
5,592 3,326 3,857 4,035 4,297 4,669 4,975
Total Noncurrent Assets
162,334 24,332 23,485 22,469 21,569 22,449 21,629
Long-Term Investments
276 66 66 76 102 115 134
Goodwill
20,386 10,229 10,269 10,107 9,962 10,605 10,408
Intangible Assets
24,110 11,424 10,747 10,044 9,339 9,626 8,876
Noncurrent Deferred & Refundable Income Taxes
608 287 464 438 479 584 401
Other Noncurrent Operating Assets
3,864 2,326 1,939 1,804 1,687 1,519 1,810
Total Liabilities & Shareholders' Equity
217,366 42,397 42,649 42,344 42,618 42,996 40,825
Total Liabilities
67,060 17,842 17,586 16,721 17,077 17,717 16,795
Total Current Liabilities
26,620 8,238 8,548 9,558 10,744 10,409 10,386
Short-Term Debt
4,308 7.00 3.00 17 24 198 750
Accounts Payable
7,596 3,702 3,615 4,126 4,895 4,280 4,039
Accrued Expenses
8,010 4,434 2,145 2,068 2,254 2,351 2,103
Current Deferred Revenue
- - 2,662 3,201 3,388 3,406 3,287
Current Deferred & Payable Income Tax Liabilities
372 95 123 146 183 174 207
Total Noncurrent Liabilities
40,440 9,604 9,038 7,163 6,333 7,308 6,409
Long-Term Debt
11,568 115 1,102 1,100 1,283 2,291 1,953
Noncurrent Deferred & Payable Income Tax Liabilities
2,960 920 893 1,220 1,119 899 478
Noncurrent Employee Benefit Liabilities
11,354 6,377 5,176 3,124 2,255 2,467 2,271
Other Noncurrent Operating Liabilities
3,590 2,192 1,867 1,719 1,676 1,651 1,707
Total Equity & Noncontrolling Interests
150,306 24,555 25,063 25,623 25,541 25,279 24,030
Total Preferred & Common Equity
149,559 24,309 24,824 25,384 25,302 25,037 23,789
Preferred Stock
0.00 - - 0.00 0.00 0.00 0.00
Total Common Equity
149,559 24,309 24,824 25,384 25,302 25,037 23,789
Common Stock
0.00 28,004 27,714 27,758 27,858 27,755 27,203
Retained Earnings
0.00 -425 - 524 250 -41 55
Accumulated Other Comprehensive Income / (Loss)
-6,720 -3,270 -2,890 -2,898 -2,806 -2,677 -3,469
Noncontrolling Interest
747 246 239 239 239 242 241

Quarterly Balance Sheets for Corteva

This table presents Corteva's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Total Assets
40,651 42,618 45,500 44,189 43,110 42,996 43,625 41,464 41,908 40,825
Total Current Assets
15,045 16,795 18,329 17,207 16,333 16,260 17,163 15,359 15,649 15,097
Cash & Equivalents
2,199 3,191 1,646 2,563 2,254 2,644 1,505 1,839 2,421 3,106
Short-Term Investments
119 124 85 53 108 98 153 120 72 63
Accounts Receivable
6,273 5,701 8,678 7,955 6,581 5,488 7,906 7,615 6,651 5,676
Inventories, net
5,415 6,811 6,585 5,628 6,320 6,899 6,183 4,893 5,674 5,432
Other Current Assets
1,039 968 1,335 1,008 1,070 1,131 1,416 892 831 820
Plant, Property, & Equipment, net
4,185 4,254 4,271 4,306 4,320 4,287 4,206 4,155 4,210 4,099
Plant, Property & Equipment, gross
8,444 8,551 8,633 8,797 8,892 8,956 9,013 9,088 9,235 9,074
Accumulated Depreciation
4,259 4,297 4,362 4,491 4,572 4,669 4,807 4,933 5,025 4,975
Total Noncurrent Assets
21,421 21,569 22,900 22,676 22,457 22,449 22,256 21,950 22,049 21,629
Long-Term Investments
91 102 87 83 106 115 123 113 128 134
Goodwill
9,791 9,962 10,508 10,539 10,441 10,605 10,553 10,490 10,629 10,408
Intangible Assets
9,461 9,339 10,137 9,985 9,795 9,626 9,446 9,238 9,084 8,876
Noncurrent Deferred & Refundable Income Taxes
407 479 508 524 554 584 551 538 564 401
Other Noncurrent Operating Assets
1,671 1,687 1,660 1,545 1,561 1,519 1,583 1,571 1,644 1,810
Total Liabilities & Shareholders' Equity
40,651 42,618 45,500 44,189 43,110 42,996 43,625 41,464 41,908 40,825
Total Liabilities
15,567 17,077 19,661 17,728 17,758 17,717 18,617 16,043 16,929 16,795
Total Current Liabilities
8,918 10,744 13,231 10,346 10,348 10,409 11,332 8,953 10,424 10,386
Short-Term Debt
1,576 24 3,787 3,023 3,724 198 2,148 2,253 3,741 750
Accounts Payable
4,140 4,895 3,957 3,379 3,678 4,280 3,606 3,300 3,753 4,039
Accrued Expenses
2,115 2,254 2,477 2,892 2,273 2,351 2,573 2,499 2,188 2,103
Current Deferred Revenue
860 3,388 2,712 656 552 3,406 2,694 413 429 3,287
Current Deferred & Payable Income Tax Liabilities
227 183 298 396 236 174 311 488 313 207
Total Noncurrent Liabilities
6,649 6,333 6,430 7,382 7,295 7,308 7,285 7,090 6,505 6,409
Long-Term Debt
1,277 1,283 1,241 2,290 2,290 2,291 2,492 2,471 1,975 1,953
Noncurrent Deferred & Payable Income Tax Liabilities
1,123 1,119 1,255 1,134 1,070 899 753 607 496 478
Noncurrent Employee Benefit Liabilities
2,628 2,255 2,242 2,236 2,228 2,467 2,453 2,452 2,473 2,271
Other Noncurrent Operating Liabilities
1,621 1,676 1,692 1,722 1,707 1,651 1,587 1,560 1,561 1,707
Total Equity & Noncontrolling Interests
25,084 25,541 25,839 26,461 25,467 25,279 25,008 25,421 24,979 24,030
Total Preferred & Common Equity
24,844 25,302 25,599 26,220 25,226 25,037 24,767 25,179 24,737 23,789
Preferred Stock
0.00 0.00 0.00 0.00 239 0.00 0.00 0.00 239 0.00
Total Common Equity
24,844 25,302 25,599 26,220 25,226 25,037 24,767 25,179 24,737 23,789
Common Stock
27,822 27,858 27,851 27,884 27,902 27,755 27,475 27,511 27,525 27,203
Retained Earnings
614 250 487 1,013 325 -41 302 992 98 55
Accumulated Other Comprehensive Income / (Loss)
-3,592 -2,806 -2,739 -2,677 -3,001 -2,677 -3,010 -3,324 -2,886 -3,469
Noncontrolling Interest
240 239 240 241 241 242 241 242 242 241

Annual Metrics and Ratios for Corteva

This table displays calculated financial ratios and metrics derived from Corteva's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - -
Revenue Growth
0.00% -3.09% 2.68% 10.11% 11.50% -1.31% -1.85%
EBITDA Growth
0.00% 186.50% 11.33% 90.77% 9.17% -5.14% 5.71%
EBIT Growth
0.00% 97.39% 531.14% 230.00% -36.66% -11.89% 13.73%
NOPAT Growth
0.00% 94.24% 312.77% 40.32% 67.15% 14.44% -19.87%
Net Income Growth
0.00% 81.28% 174.50% 152.35% -34.54% -35.49% 23.03%
EPS Growth
0.00% 81.07% 171.09% 160.44% -33.33% -34.81% 26.21%
Operating Cash Flow Growth
0.00% 121.53% 92.90% 32.12% -37.26% 205.38% -17.09%
Free Cash Flow Firm Growth
0.00% 0.00% -95.45% -10.65% -97.72% 109.92% 5,618.87%
Invested Capital Growth
0.00% -51.80% -2.34% -0.84% 5.93% 6.32% -5.95%
Revenue Q/Q Growth
0.00% 113.31% 34.16% 1.77% 2.02% -0.68% 1.63%
EBITDA Q/Q Growth
0.00% -57.15% -42.09% 9.73% -3.16% 119.95% 21.50%
EBIT Q/Q Growth
0.00% -104.31% -11.00% 15.17% -21.82% -6.62% 37.22%
NOPAT Q/Q Growth
0.00% -107.25% -3.18% -4.16% 27.01% -18.86% 2.54%
Net Income Q/Q Growth
0.00% -128.66% 51.08% 7.15% -15.60% -20.95% 29.99%
EPS Q/Q Growth
0.00% 0.00% 10.98% 7.24% -15.51% -21.37% 30.00%
Operating Cash Flow Q/Q Growth
0.00% 11.46% -3.37% 9.87% 327.53% 103.62% 649.05%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% -60.48% 5.16% -12.33% 103.18% 34.07%
Invested Capital Q/Q Growth
0.00% -14.81% -9.35% -9.73% -8.21% -13.80% -16.54%
Profitability Metrics
- - - - - - -
Gross Margin
30.37% 38.07% 40.16% 41.11% 40.21% 42.41% 43.64%
EBITDA Margin
-13.79% 12.31% 13.34% 23.12% 22.64% 21.76% 23.43%
Operating Margin
-46.45% -2.76% 3.57% 6.57% 8.97% 10.30% 10.69%
EBIT Margin
-44.71% -1.21% 5.06% 15.18% 8.62% 7.70% 8.92%
Profit (Net Income) Margin
-35.19% -6.80% 4.93% 11.30% 6.63% 4.34% 5.44%
Tax Burden Percent
73.86% 297.78% 103.85% 75.40% 81.21% 68.34% 72.08%
Interest Burden Percent
106.54% 189.22% 93.75% 98.74% 94.75% 82.43% 84.55%
Effective Tax Rate
0.00% 0.00% -12.00% 22.34% 14.73% 13.91% 32.31%
Return on Invested Capital (ROIC)
-9.80% -0.76% 2.52% 3.59% 5.86% 6.32% 5.06%
ROIC Less NNEP Spread (ROIC-NNEP)
-9.43% 0.53% -3.39% -27.42% 12.15% 69.30% 68.03%
Return on Net Nonoperating Assets (RNNOA)
6.46% -0.31% 0.31% 3.39% -1.33% -3.38% -1.34%
Return on Equity (ROE)
-3.34% -1.08% 2.83% 6.98% 4.53% 2.94% 3.73%
Cash Return on Invested Capital (CROIC)
0.00% 69.14% 4.89% 4.44% 0.10% 0.20% 11.19%
Operating Return on Assets (OROA)
-2.94% -0.13% 1.69% 5.59% 3.54% 3.10% 3.60%
Return on Assets (ROA)
-2.31% -0.72% 1.65% 4.16% 2.73% 1.75% 2.19%
Return on Common Equity (ROCE)
-3.33% -1.07% 2.80% 6.91% 4.48% 2.91% 3.69%
Return on Equity Simple (ROE_SIMPLE)
-3.36% -3.87% 2.82% 6.97% 4.58% 2.98% 3.86%
Net Operating Profit after Tax (NOPAT)
-4,646 -267 569 798 1,335 1,527 1,224
NOPAT Margin
-32.52% -1.93% 4.00% 5.10% 7.65% 8.87% 7.24%
Net Nonoperating Expense Percent (NNEP)
-0.37% -1.29% 5.91% 31.01% -6.29% -62.98% -62.97%
Return On Investment Capital (ROIC_SIMPLE)
- - - - 4.97% 5.50% 4.58%
Cost of Revenue to Revenue
69.63% 61.93% 59.84% 58.89% 59.79% 57.59% 56.36%
SG&A Expenses to Revenue
21.29% 22.14% 21.40% 20.50% 18.18% 18.44% 18.90%
R&D to Revenue
9.48% 8.28% 8.03% 7.58% 6.97% 7.76% 8.29%
Operating Expenses to Revenue
76.83% 40.83% 36.59% 34.54% 31.25% 32.11% 32.95%
Earnings before Interest and Taxes (EBIT)
-6,388 -167 720 2,376 1,505 1,326 1,508
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-1,970 1,704 1,897 3,619 3,951 3,748 3,962
Valuation Ratios
- - - - - - -
Price to Book Value (P/BV)
0.00 0.86 1.12 1.33 1.62 1.33 1.65
Price to Tangible Book Value (P/TBV)
0.00 7.89 7.31 6.43 6.84 6.95 8.69
Price to Revenue (P/Rev)
0.00 1.51 1.96 2.15 2.35 1.94 2.32
Price to Earnings (P/E)
0.00 0.00 40.87 19.13 35.77 45.42 43.16
Dividend Yield
0.00% 0.93% 1.74% 1.17% 1.27% 1.31% 1.16%
Earnings Yield
0.00% 0.00% 2.45% 5.23% 2.80% 2.20% 2.32%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.85 1.13 1.37 1.67 1.34 1.66
Enterprise Value to Revenue (EV/Rev)
0.00 1.41 1.78 1.94 2.24 1.93 2.29
Enterprise Value to EBITDA (EV/EBITDA)
0.00 11.43 13.34 8.39 9.91 8.87 9.79
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 35.16 12.79 26.02 25.08 25.72
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 44.49 38.05 29.34 21.78 31.70
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 18.20 12.26 11.14 22.89 6.37 8.95
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.80 22.93 30.80 1,738.05 703.19 14.34
Leverage & Solvency
- - - - - - -
Debt to Equity
0.11 0.01 0.04 0.04 0.05 0.10 0.11
Long-Term Debt to Equity
0.08 0.00 0.04 0.04 0.05 0.09 0.08
Financial Leverage
-0.68 -0.60 -0.09 -0.12 -0.11 -0.05 -0.02
Leverage Ratio
1.45 1.49 1.71 1.68 1.66 1.68 1.70
Compound Leverage Factor
1.54 2.81 1.61 1.66 1.57 1.39 1.44
Debt to Total Capital
9.55% 0.49% 4.22% 4.18% 4.87% 8.96% 10.11%
Short-Term Debt to Total Capital
2.59% 0.03% 0.01% 0.06% 0.09% 0.71% 2.81%
Long-Term Debt to Total Capital
6.96% 0.47% 4.21% 4.11% 4.78% 8.25% 7.31%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.45% 1.00% 0.91% 0.89% 0.89% 0.87% 0.90%
Common Equity to Total Capital
90.00% 98.51% 94.86% 94.93% 94.24% 90.16% 88.99%
Debt to EBITDA
-8.06 0.07 0.58 0.31 0.33 0.66 0.68
Net Debt to EBITDA
-5.61 -1.01 -1.45 -0.97 -0.53 -0.10 -0.15
Long-Term Debt to EBITDA
-5.87 0.07 0.58 0.30 0.32 0.61 0.49
Debt to NOPAT
-3.42 -0.46 1.94 1.40 0.98 1.63 2.21
Net Debt to NOPAT
-2.38 6.41 -4.84 -4.39 -1.58 -0.24 -0.49
Long-Term Debt to NOPAT
-2.49 -0.43 1.94 1.38 0.96 1.50 1.60
Altman Z-Score
0.00 1.15 1.51 1.95 2.15 1.79 2.08
Noncontrolling Interest Sharing Ratio
0.50% 0.57% 0.98% 0.94% 0.93% 0.95% 0.98%
Liquidity Ratios
- - - - - - -
Current Ratio
1.73 1.64 1.73 1.63 1.56 1.56 1.45
Quick Ratio
0.57 0.89 1.02 0.98 0.84 0.79 0.85
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 24,281 1,104 986 23 47 2,705
Operating Cash Flow to CapEx
32.18% 92.00% 434.53% 475.92% 141.41% 439.08% 362.81%
Free Cash Flow to Firm to Interest Expense
0.00 162.96 24.53 32.88 0.29 0.20 11.61
Operating Cash Flow to Interest Expense
1.16 7.18 45.87 90.90 21.66 22.42 18.59
Operating Cash Flow Less CapEx to Interest Expense
-2.44 -0.62 35.31 71.80 6.34 17.32 13.47
Efficiency Ratios
- - - - - - -
Asset Turnover
0.07 0.11 0.33 0.37 0.41 0.40 0.40
Accounts Receivable Turnover
1.36 1.73 2.72 3.22 3.32 3.08 3.03
Inventory Turnover
0.94 1.10 1.72 1.83 1.74 1.45 1.55
Fixed Asset Turnover
1.57 2.03 3.18 3.59 4.07 4.03 4.03
Accounts Payable Turnover
1.31 1.52 2.33 2.38 2.31 2.16 2.29
Days Sales Outstanding (DSO)
268.76 211.52 134.20 113.51 109.91 118.54 120.50
Days Inventory Outstanding (DIO)
389.66 333.12 212.68 199.17 209.69 252.23 236.16
Days Payable Outstanding (DPO)
278.70 240.45 156.97 153.22 157.76 168.79 159.33
Cash Conversion Cycle (CCC)
379.71 304.19 189.91 159.45 161.85 201.97 197.34
Capital & Investment Metrics
- - - - - - -
Invested Capital
47,390 22,842 22,307 22,119 23,431 24,911 23,430
Invested Capital Turnover
0.30 0.39 0.63 0.70 0.77 0.71 0.70
Increase / (Decrease) in Invested Capital
0.00 -24,548 -535 -188 1,312 1,480 -1,481
Enterprise Value (EV)
0.00 19,477 25,314 30,377 39,159 33,258 38,789
Market Capitalization
0.00 20,944 27,831 33,642 41,030 33,384 39,148
Book Value per Share
$0.00 $32.48 $33.32 $34.82 $35.41 $35.53 $34.61
Tangible Book Value per Share
$0.00 $3.55 $5.11 $7.18 $8.40 $6.82 $6.55
Total Capital
166,182 24,677 26,168 26,740 26,848 27,768 26,733
Total Debt
15,876 122 1,105 1,117 1,307 2,489 2,703
Total Long-Term Debt
11,568 115 1,102 1,100 1,283 2,291 1,953
Net Debt
11,050 -1,713 -2,756 -3,504 -2,110 -368 -600
Capital Expenditures (CapEx)
1,501 1,163 475 573 1,210 1,190 1,194
Debt-free, Cash-free Net Working Capital (DFCFNWC)
19,082 3,519 2,428 1,460 2,760 3,307 2,292
Debt-free Net Working Capital (DFNWC)
23,632 5,288 6,223 6,005 6,075 6,049 5,461
Net Working Capital (NWC)
19,324 5,281 6,220 5,988 6,051 5,851 4,711
Net Nonoperating Expense (NNE)
381 674 -132 -971 177 780 305
Net Nonoperating Obligations (NNO)
-102,916 -1,713 -2,756 -3,504 -2,110 -368 -600
Total Depreciation and Amortization (D&A)
4,418 1,871 1,177 1,243 2,446 2,422 2,454
Debt-free, Cash-free Net Working Capital to Revenue
133.56% 25.42% 17.08% 9.33% 15.81% 19.20% 13.56%
Debt-free Net Working Capital to Revenue
165.41% 38.19% 43.77% 38.36% 34.80% 35.12% 32.30%
Net Working Capital to Revenue
135.26% 38.14% 43.75% 38.25% 34.67% 33.97% 27.86%
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
($6.76) ($1.28) $0.91 $2.39 $1.59 $1.04 $1.31
Adjusted Weighted Average Basic Shares Outstanding
0.00 749.40M 744.06M 727.02M 712.82M 701.78M 685.56M
Adjusted Diluted Earnings per Share
($6.76) ($1.28) $0.91 $2.37 $1.58 $1.03 $1.30
Adjusted Weighted Average Diluted Shares Outstanding
0.00 749.40M 744.06M 727.02M 712.82M 701.78M 685.56M
Adjusted Basic & Diluted Earnings per Share
($6.76) ($1.28) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 749.40M 744.06M 727.02M 712.82M 701.78M 685.56M
Normalized Net Operating Profit after Tax (NOPAT)
-1,008 -112 590 1,023 1,644 1,817 1,419
Normalized NOPAT Margin
-7.06% -0.81% 4.15% 6.53% 9.42% 10.55% 8.39%
Pre Tax Income Margin
-47.64% -2.28% 4.75% 14.99% 8.17% 6.35% 7.54%
Debt Service Ratios
- - - - - - -
EBIT to Interest Expense
-15.28 -1.12 16.00 79.20 19.05 5.69 6.47
NOPAT to Interest Expense
-11.11 -1.79 12.64 26.61 16.89 6.55 5.25
EBIT Less CapEx to Interest Expense
-18.87 -8.93 5.44 60.10 3.73 0.58 1.35
NOPAT Less CapEx to Interest Expense
-14.71 -9.60 2.09 7.51 1.58 1.45 0.13
Payout Ratios
- - - - - - -
Dividend Payout Ratio
-55.82% 54.30% 63.91% 22.44% 36.10% 58.77% 254.30%
Augmented Payout Ratio
-55.82% 51.65% 103.14% 76.14% 122.45% 159.97% 364.09%

Quarterly Metrics and Ratios for Corteva

This table displays calculated financial ratios and metrics derived from Corteva's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
17.12% 9.95% 6.15% -3.31% -6.73% -3.09% -8.03% 1.11% -10.19% 7.31%
EBITDA Growth
-161.54% -22.63% -4.64% -11.96% 60.00% 186.17% 17.58% 51.34% 156.25% -40.41%
EBIT Growth
-2,462.50% -166.01% 14.14% -13.18% -2.12% -56.29% -35.19% 20.41% -46.89% 156.71%
NOPAT Growth
82.77% 63.01% 20.41% 16.51% 40.90% -509.18% -29.35% 13.45% -94.09% 37.30%
Net Income Growth
-1,125.00% -132.92% 5.64% -26.23% 3.05% -373.58% -29.38% 47.28% -63.84% 84.46%
EPS Growth
-1,250.00% -131.82% 6.41% -24.81% 2.17% -400.00% -27.71% 51.00% -68.89% 85.71%
Operating Cash Flow Growth
-1,421.02% 69.46% -21.28% -26.78% 96.08% 30.29% -68.65% -33.99% -8.57% 21.27%
Free Cash Flow Firm Growth
14.32% -1,077.94% -361.59% -11,949.34% -170.80% -19.96% 162.53% 181.40% 114.20% 188.15%
Invested Capital Growth
4.18% 5.93% 13.05% 14.84% 13.20% 6.32% -4.07% -3.45% -2.85% -5.95%
Revenue Q/Q Growth
-55.58% 37.74% 27.69% 23.77% -57.15% 43.13% 21.18% 36.06% -61.94% 71.02%
EBITDA Q/Q Growth
-113.14% 320.50% 223.66% 38.57% -105.97% 1,677.50% 234.08% 78.36% -97.78% 1,571.11%
EBIT Q/Q Growth
-128.15% 55.82% 583.23% 44.49% -133.10% 32.38% 300.38% 168.45% -140.38% 126.10%
NOPAT Q/Q Growth
-130.99% 93.16% 3,678.93% 53.67% -115.72% 29.54% 376.75% 146.75% -126.89% 77.24%
Net Income Q/Q Growth
-133.74% 83.84% 1,230.19% 19.70% -144.35% 21.07% 268.53% 149.65% -149.34% 92.51%
EPS Q/Q Growth
-134.59% 84.78% 1,285.71% 20.48% -145.00% 22.22% 271.43% 151.67% -150.33% 93.42%
Operating Cash Flow Q/Q Growth
-341.39% 324.47% -164.04% 124.52% -112.93% 7,556.19% -179.91% 109.60% -121.27% 8,428.07%
Free Cash Flow Firm Q/Q Growth
-5,826.75% -1.95% -100.29% -1.33% -30.88% 54.84% 200.72% 31.91% -77.17% 180.42%
Invested Capital Q/Q Growth
0.83% -8.21% 23.98% 0.09% -0.61% -13.80% 11.87% 0.74% 0.00% -16.54%
Profitability Metrics
- - - - - - - - - -
Gross Margin
32.34% 34.38% 43.26% 48.11% 36.45% 36.17% 43.23% 52.26% 32.72% 37.25%
EBITDA Margin
-7.20% 11.53% 19.80% 22.17% -3.09% 34.04% 25.31% 33.18% 1.93% 18.90%
Operating Margin
-14.44% -0.47% 17.98% 21.51% -9.15% -4.51% 13.85% 24.82% -19.78% 3.24%
EBIT Margin
-13.61% -4.37% 16.52% 19.29% -14.90% -7.04% 11.64% 22.97% -24.38% 3.72%
Profit (Net Income) Margin
-11.81% -1.39% 12.26% 11.86% -12.28% -6.77% 9.42% 17.28% -22.40% -0.98%
Tax Burden Percent
82.83% -2.16% 77.19% 66.14% 71.62% 77.71% 87.76% 78.92% 82.31% -44.32%
Interest Burden Percent
104.76% -1,467.66% 96.16% 92.97% 115.03% 123.75% 92.16% 95.30% 111.64% 59.46%
Effective Tax Rate
0.00% -6.61% 21.78% 18.82% 0.00% 0.00% 21.99% 21.08% 0.00% 156.82%
Return on Invested Capital (ROIC)
-6.91% -0.38% 9.11% 11.25% -4.08% -2.25% 6.39% 11.59% -8.09% -1.29%
ROIC Less NNEP Spread (ROIC-NNEP)
288.71% 0.82% 3.20% -25.11% -11.93% 8.58% 4.34% 6.22% -14.18% -8.37%
Return on Net Nonoperating Assets (RNNOA)
-0.18% -0.09% 0.18% -0.89% -0.91% -0.42% 0.52% 0.63% -1.83% 0.16%
Return on Equity (ROE)
-7.10% -0.47% 9.30% 10.36% -5.00% -2.67% 6.91% 12.22% -9.92% -1.12%
Cash Return on Invested Capital (CROIC)
0.10% 0.10% -6.94% -7.57% -5.47% 0.20% 8.89% 8.62% 7.08% 11.19%
Operating Return on Assets (OROA)
-5.70% -1.79% 6.65% 7.95% -6.17% -2.83% 4.40% 9.07% -9.54% 1.50%
Return on Assets (ROA)
-4.94% -0.57% 4.94% 4.89% -5.08% -2.72% 3.56% 6.82% -8.77% -0.40%
Return on Common Equity (ROCE)
-7.03% -0.47% 9.21% 10.27% -4.95% -2.64% 6.84% 12.10% -9.83% -1.11%
Return on Equity Simple (ROE_SIMPLE)
5.52% 0.00% 4.65% 3.57% 3.75% 0.00% 2.31% 3.61% 2.86% 0.00%
Net Operating Profit after Tax (NOPAT)
-281 -19 687 1,055 -166 -117 485 1,197 -322 -73
NOPAT Margin
-10.11% -0.50% 14.06% 17.46% -6.41% -3.15% 10.80% 19.59% -13.84% -1.84%
Net Nonoperating Expense Percent (NNEP)
-295.63% -1.20% 5.91% 36.36% 7.85% -10.82% 2.05% 5.37% 6.10% 7.09%
Return On Investment Capital (ROIC_SIMPLE)
- -0.07% - - - -0.42% - - - -0.27%
Cost of Revenue to Revenue
67.66% 65.62% 56.74% 51.89% 63.55% 63.83% 56.77% 47.74% 67.28% 62.75%
SG&A Expenses to Revenue
23.66% 19.97% 14.86% 17.29% 25.87% 19.83% 16.38% 17.24% 28.85% 18.48%
R&D to Revenue
11.24% 8.89% 6.47% 5.44% 12.93% 9.63% 7.39% 5.84% 14.96% 9.18%
Operating Expenses to Revenue
46.78% 34.85% 25.29% 26.60% 45.60% 40.68% 29.39% 27.44% 52.49% 34.01%
Earnings before Interest and Taxes (EBIT)
-378 -167 807 1,166 -386 -261 523 1,404 -567 148
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-200 441 967 1,340 -80 1,262 1,137 2,028 45 752
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.63 1.62 1.66 1.53 1.42 1.33 1.64 1.49 1.65 1.65
Price to Tangible Book Value (P/TBV)
7.23 6.84 8.57 7.06 7.19 6.95 8.52 6.90 8.10 8.69
Price to Revenue (P/Rev)
2.36 2.35 2.39 2.29 2.07 1.94 2.41 2.22 2.45 2.32
Price to Earnings (P/E)
29.69 35.77 36.05 43.58 38.44 45.42 72.70 41.87 58.56 43.16
Dividend Yield
1.01% 1.27% 1.24% 1.33% 1.50% 1.31% 1.09% 1.19% 1.11% 1.16%
Earnings Yield
3.37% 2.80% 2.77% 2.29% 2.60% 2.20% 1.38% 2.39% 1.71% 2.32%
Enterprise Value to Invested Capital (EV/IC)
1.61 1.67 1.58 1.48 1.38 1.34 1.57 1.44 1.58 1.66
Enterprise Value to Revenue (EV/Rev)
2.40 2.24 2.59 2.46 2.30 1.93 2.60 2.40 2.66 2.29
Enterprise Value to EBITDA (EV/EBITDA)
10.07 9.91 20.07 20.46 23.41 8.87 25.11 12.91 13.58 9.79
Enterprise Value to EBIT (EV/EBIT)
21.35 26.02 28.61 30.17 28.09 25.08 41.98 31.63 40.29 25.72
Enterprise Value to NOPAT (EV/NOPAT)
39.11 29.34 31.62 25.38 21.19 21.78 32.43 27.74 37.10 31.70
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 22.89 157.78 0.00 15.55 6.37 0.00 0.00 0.00 8.95
Enterprise Value to Free Cash Flow (EV/FCFF)
1,598.80 1,738.05 0.00 0.00 0.00 703.19 17.28 16.45 21.94 14.34
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.11 0.05 0.19 0.20 0.24 0.10 0.19 0.19 0.23 0.11
Long-Term Debt to Equity
0.05 0.05 0.05 0.09 0.09 0.09 0.10 0.10 0.08 0.08
Financial Leverage
0.00 -0.11 0.06 0.04 0.08 -0.05 0.12 0.10 0.13 -0.02
Leverage Ratio
1.63 1.66 1.70 1.62 1.66 1.68 1.75 1.65 1.69 1.70
Compound Leverage Factor
1.71 -24.37 1.64 1.51 1.91 2.08 1.62 1.57 1.88 1.01
Debt to Total Capital
10.21% 4.87% 16.29% 16.72% 19.10% 8.96% 15.65% 15.67% 18.62% 10.11%
Short-Term Debt to Total Capital
5.64% 0.09% 12.27% 9.51% 11.83% 0.71% 7.25% 7.47% 12.19% 2.81%
Long-Term Debt to Total Capital
4.57% 4.78% 4.02% 7.21% 7.27% 8.25% 8.41% 8.20% 6.43% 7.31%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.76% 0.00% 0.00% 0.00% 0.78% 0.00%
Noncontrolling Interests to Total Capital
0.86% 0.89% 0.78% 0.76% 0.77% 0.87% 0.81% 0.80% 0.79% 0.90%
Common Equity to Total Capital
88.93% 94.24% 82.93% 82.52% 80.13% 90.16% 83.54% 83.53% 80.59% 88.99%
Debt to EBITDA
0.70 0.33 2.20 2.52 3.53 0.66 2.66 1.51 1.75 0.68
Net Debt to EBITDA
0.11 -0.53 1.40 1.24 2.08 -0.10 1.64 0.85 0.95 -0.15
Long-Term Debt to EBITDA
0.31 0.32 0.54 1.09 1.34 0.61 1.43 0.79 0.61 0.49
Debt to NOPAT
2.72 0.98 3.46 3.13 3.20 1.63 3.44 3.24 4.79 2.21
Net Debt to NOPAT
0.42 -1.58 2.21 1.54 1.88 -0.24 2.12 1.82 2.59 -0.49
Long-Term Debt to NOPAT
1.22 0.96 0.85 1.35 1.22 1.50 1.85 1.69 1.65 1.60
Altman Z-Score
2.15 2.02 1.89 2.06 1.76 1.67 1.91 2.14 1.95 1.97
Noncontrolling Interest Sharing Ratio
0.96% 0.93% 0.93% 0.92% 0.95% 0.95% 0.95% 0.93% 0.96% 0.98%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.69 1.56 1.39 1.66 1.58 1.56 1.51 1.72 1.50 1.45
Quick Ratio
0.96 0.84 0.79 1.02 0.86 0.79 0.84 1.07 0.88 0.85
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-1,306 -1,331 -2,666 -2,702 -3,536 -1,597 1,667 2,199 502 1,408
Operating Cash Flow to CapEx
-444.68% 2,072.07% -2,192.72% 820.20% -64.81% 1,006.30% -1,886.49% 235.09% -37.01% 2,622.65%
Free Cash Flow to Firm to Interest Expense
-72.54 -36.98 -86.01 -32.95 -60.96 -25.76 40.66 33.32 7.61 23.46
Operating Cash Flow to Interest Expense
-148.72 166.92 -106.81 9.90 -1.81 126.27 -136.20 8.12 -1.73 158.23
Operating Cash Flow Less CapEx to Interest Expense
-182.17 158.86 -111.68 8.70 -4.60 113.73 -143.41 4.67 -6.39 152.20
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.42 0.41 0.40 0.41 0.41 0.40 0.38 0.39 0.39 0.40
Accounts Receivable Turnover
2.83 3.32 2.22 2.35 2.70 3.08 2.03 2.17 2.51 3.03
Inventory Turnover
2.07 1.74 1.81 2.10 1.72 1.45 1.52 1.80 1.57 1.55
Fixed Asset Turnover
4.03 4.07 4.12 4.07 4.08 4.03 3.97 4.00 3.90 4.03
Accounts Payable Turnover
2.66 2.31 2.74 2.96 2.57 2.16 2.56 2.84 2.53 2.29
Days Sales Outstanding (DSO)
128.97 109.91 164.13 155.13 135.25 118.54 179.79 168.13 145.15 120.50
Days Inventory Outstanding (DIO)
176.64 209.69 201.44 173.90 212.80 252.23 240.25 202.54 232.89 236.16
Days Payable Outstanding (DPO)
137.48 157.76 133.04 123.11 141.77 168.79 142.31 128.58 144.29 159.33
Cash Conversion Cycle (CCC)
168.14 161.85 232.54 205.93 206.29 201.97 277.73 242.09 233.75 197.34
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
25,528 23,431 29,049 29,075 28,898 24,911 27,867 28,073 28,074 23,430
Invested Capital Turnover
0.68 0.77 0.65 0.64 0.64 0.71 0.59 0.59 0.58 0.70
Increase / (Decrease) in Invested Capital
1,025 1,312 3,353 3,757 3,370 1,480 -1,182 -1,002 -824 -1,481
Enterprise Value (EV)
41,089 39,159 45,914 43,083 39,893 33,258 43,742 40,489 44,273 38,789
Market Capitalization
40,405 41,030 42,464 40,228 35,867 33,384 40,642 37,595 40,697 39,148
Book Value per Share
$34.57 $35.41 $35.91 $36.88 $35.54 $35.53 $35.53 $36.13 $35.73 $34.61
Tangible Book Value per Share
$7.78 $8.40 $6.95 $8.01 $7.03 $6.82 $6.84 $7.82 $7.26 $6.55
Total Capital
27,937 26,848 30,867 31,774 31,481 27,768 29,648 30,145 30,695 26,733
Total Debt
2,853 1,307 5,028 5,313 6,014 2,489 4,640 4,724 5,716 2,703
Total Long-Term Debt
1,277 1,283 1,241 2,290 2,290 2,291 2,492 2,471 1,975 1,953
Net Debt
444 -2,110 3,210 2,614 3,546 -368 2,859 2,652 3,095 -600
Capital Expenditures (CapEx)
602 290 151 99 162 778 296 228 308 362
Debt-free, Cash-free Net Working Capital (DFCFNWC)
5,385 2,760 7,154 7,268 7,347 3,307 6,321 6,700 6,473 2,292
Debt-free Net Working Capital (DFNWC)
7,703 6,075 8,885 9,884 9,709 6,049 7,979 8,659 8,966 5,461
Net Working Capital (NWC)
6,127 6,051 5,098 6,861 5,985 5,851 5,831 6,406 5,225 4,711
Net Nonoperating Expense (NNE)
47 34 88 338 152 134 62 141 199 -34
Net Nonoperating Obligations (NNO)
444 -2,110 3,210 2,614 3,431 -368 2,859 2,652 3,095 -600
Total Depreciation and Amortization (D&A)
178 608 160 174 306 1,523 614 624 612 604
Debt-free, Cash-free Net Working Capital to Revenue
31.47% 15.81% 40.33% 41.46% 42.36% 19.20% 37.55% 39.64% 38.91% 13.56%
Debt-free Net Working Capital to Revenue
45.02% 34.80% 50.09% 56.38% 55.98% 35.12% 47.40% 51.23% 53.89% 32.30%
Net Working Capital to Revenue
35.81% 34.67% 28.74% 39.14% 34.51% 33.97% 34.64% 37.90% 31.41% 27.86%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.46) ($0.07) $0.84 $1.00 ($0.45) ($0.35) $0.60 $1.51 ($0.76) ($0.04)
Adjusted Weighted Average Basic Shares Outstanding
714.49M 712.82M 710.87M 709.76M 704.73M 701.78M 696.98M 692.25M 687.29M 685.56M
Adjusted Diluted Earnings per Share
($0.46) ($0.07) $0.83 $1.00 ($0.45) ($0.35) $0.60 $1.51 ($0.76) ($0.05)
Adjusted Weighted Average Diluted Shares Outstanding
714.49M 712.82M 710.87M 709.76M 704.73M 701.78M 696.98M 692.25M 687.29M 685.56M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
714.49M 712.82M 710.87M 709.76M 704.73M 701.78M 696.98M 692.25M 687.29M 685.56M
Normalized Net Operating Profit after Tax (NOPAT)
-174 32 713 1,104 -165 52 544 1,270 -300 153
Normalized NOPAT Margin
-6.28% 0.82% 14.59% 18.26% -6.35% 1.40% 12.10% 20.78% -12.88% 3.84%
Pre Tax Income Margin
-14.26% 64.08% 15.89% 17.93% -17.14% -8.71% 10.73% 21.89% -27.21% 2.21%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
-21.00 -4.64 26.03 14.22 -6.66 -4.21 12.76 21.27 -8.59 2.47
NOPAT to Interest Expense
-15.59 -0.53 22.15 12.87 -2.86 -1.89 11.83 18.14 -4.88 -1.22
EBIT Less CapEx to Interest Expense
-54.44 -12.69 21.16 13.01 -9.45 -16.76 5.54 17.82 -13.26 -3.57
NOPAT Less CapEx to Interest Expense
-49.04 -8.59 17.28 11.66 -5.65 -14.43 4.61 14.69 -9.55 -7.25
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
30.10% 36.10% 35.55% 45.78% 45.93% 58.77% 77.76% 49.34% 63.93% 254.30%
Augmented Payout Ratio
102.99% 122.45% 121.01% 124.06% 128.99% 159.97% 210.16% 151.32% 195.19% 364.09%

Frequently Asked Questions About Corteva's Financials

When does Corteva's financial year end?

According to the most recent income statement we have on file, Corteva's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Corteva's net income changed over the last 6 years?

Corteva's net income appears to be on a downward trend, with a most recent value of $919 million in 2024, falling from -$5.03 billion in 2018. The previous period was $747 million in 2023.

What is Corteva's operating income?
Corteva's total operating income in 2024 was $1.81 billion, based on the following breakdown:
  • Total Gross Profit: $7.38 billion
  • Total Operating Expenses: $5.57 billion
How has Corteva revenue changed over the last 6 years?

Over the last 6 years, Corteva's total revenue changed from $14.29 billion in 2018 to $16.91 billion in 2024, a change of 18.3%.

How much debt does Corteva have?

Corteva's total liabilities were at $16.80 billion at the end of 2024, a 5.2% decrease from 2023, and a 75.0% decrease since 2018.

How much cash does Corteva have?

In the past 6 years, Corteva's cash and equivalents has ranged from $1.76 billion in 2019 to $4.54 billion in 2018, and is currently $3.11 billion as of their latest financial filing in 2024.

How has Corteva's book value per share changed over the last 6 years?

Over the last 6 years, Corteva's book value per share changed from 0.00 in 2018 to 34.61 in 2024, a change of 3,461.3%.

Remove Ads


This page (NYSE:CTVA) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners